Annuncio pubblicitario
Italia markets close in 24 minutes

  • FTSE MIB

    33.132,10
    -54,79 (-0,17%)
     

  • Dow Jones

    39.276,89
    +112,83 (+0,29%)
     

  • Nasdaq

    17.904,09
    +45,41 (+0,25%)
     

  • Nikkei 225

    39.583,08
    +241,54 (+0,61%)
     

  • Petrolio

    81,37
    -0,37 (-0,45%)
     

  • Bitcoin EUR

    56.776,56
    -728,94 (-1,27%)
     

  • CMC Crypto 200

    1.267,67
    -16,16 (-1,26%)
     

  • Oro

    2.335,40
    -1,20 (-0,05%)
     

  • EUR/USD

    1,0717
    +0,0008 (+0,08%)
     

  • S&P 500

    5.498,37
    +15,50 (+0,28%)
     

  • HANG SENG

    17.718,61
    +2,14 (+0,01%)
     

  • Euro Stoxx 50

    4.901,13
    -1,47 (-0,03%)
     

  • EUR/GBP

    0,8475
    +0,0007 (+0,08%)
     

  • EUR/CHF

    0,9627
    +0,0010 (+0,10%)
     

  • EUR/CAD

    1,4655
    -0,0003 (-0,02%)
     

Privia Health to Participate in the Morgan Stanley Healthcare Conference

Privia Health Group, Inc.
·1 minuto per la lettura
Privia Health Group, Inc.
Privia Health Group, Inc.

ARLINGTON, Va., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to participate in a Q&A session at the Morgan Stanley Global Healthcare Conference on Wednesday, September 13, 2023 beginning at 12:15 pm ET.

The live webcast and replay of the event will be available at ir.priviahealth.com/news-and-events/events-and-presentations.

About Privia Health

Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health’s platform is led by top industry talent and exceptional physician leadership, and consists of scalable operations and end-to-end, cloud-based technology that reduces unnecessary healthcare costs, achieves better outcomes, and improves the health of patients and the well-being of providers. For more information, visit priviahealth.com.

Contact
Robert Borchert
SVP, Investor & Corporate Communications
IR@priviahealth.com
817.783.4841